Measuring VLDL₁-Triglyceride and VLDL₂-Triglyceride Kinetics in Men: Effects of Dietary Control on Day-to-Day Variability

Abstract

The aim of this study was to assess the impact of dietary control on VLDL₁- and VLDL₂-TG kinetics and associated metabolic parameters. Twelve overweight/obese men were randomized to a provided 3 day isocaloric diet with fixed macronutrient composition (diet group, n=6) or to their regular unrestricted diet (non-diet group, n=6). VLDL₁- and VLDL₂-TG turnovers were measured twice 2–4 weeks apart, using primed-constant infusion of ex vivo labeled [1-¹⁴C]VLDL₁-TG and [9,10-³H]VLDL₂-TG. Isocaloric diet intervention lowered the difference in the mean of both VLDL₂-TG secretion and clearance rate (p<0.01), and the coefficient of variation (CV) of VLDL₂-TG clearance rate (p<0.05). The difference in mean and CV of the other kinetic estimates (VLDL₁-TG secretion, clearance and oxidation rate) were lowered, but not significantly. The CV’s of total triglyceride, VLDL₁-TG, and VLDL₂-TG concentrations were significantly lowered by diet intervention compared to regular diet; total triglyceride (31%–5%, p<0.01), VLDL₁-TG (42%–9%, p<0.01), and VLDL₂-TG (36%–10%, p<0.01). In conclusion, VLDL₁- and VLDL₂-TG kinetics show great day-to-day variability, which may be diminished by diet intervention. Therefore, standardized macronutrient intake prior to study days improves the probability of demonstrating significant outcomes of cross-sectional and intervention studies of VLDL₁-TG and VLDL₂-TG kinetics and metabolism.

Key words

diet intervention - fatty acid/oxidation - human - triglycerides - VLDL kinetics

• References

• 1 Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 2004; 89: 2601-2607
• 2 Karpe F, Steiner G, Olivecrona T, Carlson LA, Hamsten A. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest 1993; 91: 748-758
• 3 Adiels M, Packard C, Caslake MJ, Stewart P, Soro A, Westerbacka J, Wennberg B, Olofsson SO, Taskinen MR, Boren J. A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions. J Lipid Res 2005; 46: 58-67
• 4 Adiels M, Boren J, Caslake MJ, Stewart P, Soro A, Westerbacka J, Wennberg B, Olofsson SO, Packard C, Taskinen MR. Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler Thromb Vasc Biol 2005; 25: 1697-1703
• 5 Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 2003; 46: 733-749
• 6 Gill JM, Brown JC, Bedford D, Wright DM, Cooney J, Hughes DA, Packard CJ, Caslake MJ. Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects. Atherosclerosis 2004; 176: 49-56
• 7 Johansen RF, Sondergaard E, Sorensen LP, Jurik AG, Christiansen JS, Nielsen S. Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes. Diabetologia 2016; 59: 833-843
• 8 Sidossis LS, Mittendorfer B, Walser E, Chinkes D, Wolfe RR. Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion. Am J Physiol 1998; 275 5 Pt 1 E798-E805
• 9 Sidossis LS, Magkos F, Mittendorfer B, Wolfe RR. Stable isotope tracer dilution for quantifying very low-density lipoprotein-triacylglycerol kinetics in man. Clin Nutr 2004; 23: 457-466
• 10 Sorensen LP, Gormsen LC, Nielsen S. VLDL-TG kinetics: a dual isotope study for quantifying VLDL-TG pool size, production rates, and fractional oxidation in humans. Am J Physiol Endocrinol Metab 2009; 297: E1324-E1330
• 11 Magkos F, Patterson BW, Mittendorfer B. Reproducibility of stable isotope-labeled tracer measures of VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics. J Lipid Res 2007; 48: 1204-1211
• 12 Magkos F, Fabbrini E, Korenblat K, Okunade AL, Patterson BW, Klein S. Reproducibility of glucose, fatty acid and VLDL kinetics and multi-organ insulin sensitivity in obese subjects with non-alcoholic fatty liver disease. Int J Obes (Lond) 2011; 35: 1233-1240
• 13 Magkos F, Patterson BW, Mittendorfer B. No effect of menstrual cycle phase on basal very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics. Am J Physiol Endocrinol Metab 2006; 291: E1243-E1249
• 14 Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325: 1196-1204
• 15 Jensen MD, Bajnarek J, Lee SY, Nielsen S, Koutsari C. Relationship between postabsorptive respiratory exchange ratio and plasma free fatty acid concentrations. J Lipid Res 2009; 50: 1863-1869
• 16 Nielsen S, Guo Z, Albu JB, Klein S, O’Brien PC, Jensen MD. Energy expenditure, sex, and endogenous fuel availability in humans. J Clin Invest 2003; 111: 981-988
• 17 Adiels M, Olofsson SO, Taskinen MR, Boren J. Diabetic dyslipidaemia. Curr Opin Lipidol 2006; 17: 238-246
• 18 Redgrave TG, Carlson LA. Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man. J Lipid Res 1979; 20: 217-229
• 19 Lindgren FT, Jensen LC, Hatch FT. Quantitation, composition and metabolism. In: blood lipids and lipoproteins. New York: Wiley; 1972: 181-274
• 20 Mills GL, Lane PA, Weech PK. The isolation and purification of plasma lipoproteins. In: A guidebook to lipoprotein technique. Amsterdam: Elsevier; 1984: 18-114
• 21 Tong H, Knapp HR, VanRollins M. A low temperature flotation method to rapidly isolate lipoproteins from plasma. J Lipid Res 1998; 39: 1696-1704
• 22 Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 1983; 55: 628-634
• 23 Sorensen LP, Sondergaard E, Nellemann B, Christiansen JS, Gormsen LC, Nielsen S. Increased VLDL-triglyceride secretion precedes impaired control of endogenous glucose production in obese, normoglycemic men. Diabetes 2011; 60: 2257-2264
• 24 Hopkins WG. Measures of reliability in sports medicine and science. Sports Med 2000; 30: 1-15
• 25 Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310
• 26 Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD. Splanchnic lipolysis in human obesity. J Clin Invest 2004; 113: 1582-1158
• 27 Goris AH, Westerterp KR. Postabsorptive respiratory quotient and food quotient-an analysis in lean and obese men and women. Eur J Clin Nutr 2000; 54: 546-550
• 28 Adiels M, Westerbacka J, Soro-Paavonen A, Hakkinen AM, Vehkavaara S, Caslake MJ, Packard C, Olofsson SO, Yki-Jarvinen H, Taskinen MR, Boren J. Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia 2007; 50: 2356-2365
• 29 Lewis GF, Uffelman KD, Szeto LW, Steiner G. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL ApoB production in normal weight and obese individuals. Diabetes 1993; 42: 833-842